COVID-19

Although the public health emergency for COVID-19 is officially over, infection rates, precautions, and safety measures for communities around the United States still need to be addressed.

In a recent study, significant maternal mortality was found in mothers infected with COVID-19 during pregnancy, with worse outcomes during the second wave of the pandemic compared to the first.

In a recent review, increased requests for telemedicine abortion and decreased in-person visits to abortion clinics were observed.

In a recent study, greater levels of prenatal concern were associated with higher risks of anxiety, insomnia, and depression.

In a recent study, Developmental Assessment of Young Children, second edition scores for neurodevelopmental outcomes did not differ between infants exposed to maternal COVID-19 during pregnancy and those not exposed.

In a recent study, investigators found changes in fertility rates during the COVID-19 pandemic varied, with differences in states’ political leanings and social distancing efforts linked to this variety in impact.

In a recent study, outcomes on the human oocyte and early embryo development did not differ between patients infected and not infected with COVID-19.

In a recent study, the number of postpartum opioid prescriptions increased at a greater rate than forecasted during the COVID-19 pandemic.

Investigators studied 2 infants experiencing seizures, small head size, and developmental delays born of mothers who had contracted COVID-19 during pregnancy.

In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.

New meta-analysis show patient demographics—as well as their pre-existing comorbidities and COVID-19 vaccination status—may significantly define their risk of long-term conditions.

In a recent study, women who experienced intimate partner violence early in the COVID-19 pandemic reported worse mental health symptoms and modifiable health factors.

A booster dose of mRNA COVID-19 vaccination during pregnancy increases protection of infants from infection and related hospitalization.

A new study offers insights into future guidelines for certain populations of pregnant women during a national pandemic.

In a recent analysis, worse maternal and neonatal outcomes were found when mothers were infected with COVID-19 close to delivery.

“Vaccination coverage among pregnant women remains a priority,” the study authors noted.

Jeanette Carpenter, MD, MSCI, maternal-fetal medicine specialist at Pediatrix Medical Group, discussed a recently published study regarding pregnant COVID-19 patients who also had disseminated intravascular coagulation (DIC).

In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.

In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.

As the COVID-19 pandemic continues, now in its third year, we have learned and continue to learn much about the cardiovascular complications that arise as a result of the novel coronavirus infection.

Infants of fully vaccinated mothers had fewer cases of hospitalization from COVID-19 than those unvaccinated.

Novavax joins the growing list of COVID-19 vaccines including vaccines from Pfizer-BioNTech, Moderna, and Johnson & Johnson’s Janssen

Study examines funding sources for 18 months of pandemic in 2020, 2021.

A 4-week-old boy presents with creamy white patches on his lips, right and left buccal mucosa, palate, and tongue.

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.